PCK 21.2% 4.0¢ painchek ltd

Ann: US nursing home study to pave way for FDA De Novo clearance, page-3

  1. 27,131 Posts.
    lightbulb Created with Sketch. 1757
    Why are you surprised? PCK always said they were going to commence clinical trial in the US needed for FDA approval and as expected APS will be the used as the comparator but do the RCA nurse in the US have experience or even trained in APS.....
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.007(21.2%)
Mkt cap ! $65.43M
Open High Low Value Volume
3.5¢ 4.0¢ 3.5¢ $114.1K 2.979M

Buyers (Bids)

No. Vol. Price($)
2 503170 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 5683729 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.